indomethacin has been researched along with Acquired Nephrogenic Diabetes Insipidus in 10 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Excerpt | Relevance | Reference |
---|---|---|
" We report a case of congenital nephrogenic diabetes insipidus that was complicated by paradoxical water intoxication secondary to liberal water intake and the initiation of hydrochlorothiazide and indomethacin combination therapy." | 3.75 | Nephrogenic diabetes insipidus: treat with caution. ( Boussemart, T; Champion, G; Martin-Coignard, D; Nsota, J, 2009) |
"Indomethacin 150 mg was started and urine volume immediately fell to one-half." | 2.40 | Emergency treatment of lithium-induced diabetes insipidus with nonsteroidal anti-inflammatory drugs. ( Kjellstrand, C; Lam, SS, 1997) |
"Two children with nephrogenic diabetes insipidus (NDI) were treated with oral indomethacin (0." | 1.42 | Response to low dose indomethacin in two children with nephrogenic diabetes insipidus. ( Dayal, D; Kumar Bhalla, A; Kumar, R; Verma Attri, S, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Peng, D | 1 |
Dai, Y | 1 |
Xu, X | 1 |
Caletti, MG | 1 |
Balestracci, A | 1 |
Di Pinto, D | 1 |
Schreuder, MF | 1 |
Koster-Kamphuis, L | 1 |
Dayal, D | 1 |
Verma Attri, S | 1 |
Kumar Bhalla, A | 1 |
Kumar, R | 1 |
Bockenhauer, D | 1 |
Cruwys, M | 1 |
Kleta, R | 1 |
Halperin, LF | 1 |
Wildgoose, P | 1 |
Souma, T | 1 |
Nukiwa, N | 1 |
Cheema-Dhadli, S | 1 |
Chong, CK | 1 |
Kamel, KS | 1 |
Davids, MR | 1 |
Halperin, ML | 1 |
Boussemart, T | 1 |
Nsota, J | 1 |
Martin-Coignard, D | 1 |
Champion, G | 1 |
Le Roy, V | 1 |
Delmas, Y | 1 |
Verdoux, H | 1 |
Zaki, M | 1 |
Schöneberg, T | 1 |
Al Ajrawi, T | 1 |
Al Said, AN | 1 |
Sangkuhl, K | 1 |
Römpler, H | 1 |
Höhler, T | 1 |
Teuber, G | 1 |
Wanitschke, R | 1 |
Meyer zum Büschenfeld, KH | 1 |
Lam, SS | 1 |
Kjellstrand, C | 1 |
2 reviews available for indomethacin and Acquired Nephrogenic Diabetes Insipidus
Article | Year |
---|---|
[Chronic renal complications induced by lithium].
Topics: Amiloride; Anti-Inflammatory Agents, Non-Steroidal; Antimanic Agents; Bipolar Disorder; Diabetes Ins | 2009 |
Emergency treatment of lithium-induced diabetes insipidus with nonsteroidal anti-inflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Creatinine; Diabetes Insipidus, Nephrogenic; Female; Humans | 1997 |
8 other studies available for indomethacin and Acquired Nephrogenic Diabetes Insipidus
Article | Year |
---|---|
Identification of a novel X-linked arginine-vasopressin receptor 2 mutation in nephrogenic diabetes insipidus: Case report and pedigree analysis.
Topics: Asian People; Diabetes Insipidus, Nephrogenic; Humans; Hydrochlorothiazide; Indomethacin; Receptors, | 2019 |
Pre- and post-treatment urinary tract findings in children with nephrogenic diabetes insipidus.
Topics: Amiloride; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Combined Modality Thera | 2014 |
Poiseuille's law in polyuria.
Topics: Amiloride; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Insipidus, Nephrogenic; Diuretics; Huma | 2014 |
Response to low dose indomethacin in two children with nephrogenic diabetes insipidus.
Topics: Child; Child, Preschool; Diabetes Insipidus, Nephrogenic; Dose-Response Relationship, Drug; Humans; | 2015 |
Antenatal Bartter's syndrome: why is this not a lethal condition?
Topics: Animals; Aquaporin 1; Bartter Syndrome; Chlorides; Diabetes Insipidus, Nephrogenic; Humans; Hyperald | 2008 |
Nephrogenic diabetes insipidus: treat with caution.
Topics: Amiloride; Combined Modality Therapy; Cyclooxygenase Inhibitors; Diabetes Insipidus, Nephrogenic; Di | 2009 |
Nephrogenic diabetes insipidus, thiazide treatment and renal cell carcinoma.
Topics: Amino Acid Sequence; Aquaporin 2; Carcinoma, Renal Cell; Cardiovascular Agents; Diabetes Insipidus, | 2006 |
Indomethacin treatment in amphotericin B induced nephrogenic diabetes insipidus.
Topics: Amphotericin B; Diabetes Insipidus, Nephrogenic; Diuresis; Female; Humans; Indomethacin; Kidney; Leu | 1994 |